Skip to content

Clinical trials

Completed Hypercholesterolemia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Status: Completed Country / region: Netherlands Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20042
20055
20065
20071
20082
20102
20112
20128
201311
20142
20151
20166
20172
20182
20191
20201
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen14
Sanofi10
Kowa Research Europe6
AstraZeneca5
Maastricht University Medical Center5
Kastle Therapeutics, LLC4
NewAmsterdam Pharma3
Eli Lilly and Company2
Esperion Therapeutics, Inc.2
Amsterdam UMC, location VUmc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia63
Dyslipidemias16
Hyperlipidemias9
Atherosclerosis6
Hyperlipoproteinemia Type II6
Homozygous Familial Hypercholesterolemia5
Lipid Metabolism Disorders4
Metabolic Diseases4
Cardiovascular Diseases2
Coronary Disease2

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.